Navigation Links
MultiCell Technologies Updates Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer in vitro Models
Date:8/10/2012

WOONSOCKET, R.I., Aug. 10, 2012 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the updated preclinical research results for MCT-465 and MCT-485.  MCT-485 showed in vitro dose-effect cytotoxicity on several human hepatocellular carcinoma cell lines.  MCT-485 induced robust TNFalpha and some IL-6 expression.  In contrast, MCT-465 showed no cytotoxicity or anti-proliferative effect.  The research results support further mechanistic and in vivo studies exploring the safety, effectiveness and utility of MCT-465 and MCT-485 as novel therapeutic agents as a treatment for hepatocellular carcinoma and other cancers.

Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and a leading cause of cancer death.  Current pharmacological approaches for the treatment of human HCC are very limited in their efficacy.  A potential role for noncoding double stranded RNAs such as MCT-465 and MCT-485 in the control of tumors has recently emerged in a variety of models with recognition of their ability to stimulate an immune response or directly affect cell death.

According to the National Cancer Institute, annually in the United States there are approximately 21,400 new cases of primary liver cancer and intrahepatic bile duct cancer, and approximately 18,400 of those cases resulted in death.  Primary liver cancer, resulting from Hepatitis B and Hepatitis C infection, is the most common cancer in some parts of the world with more than 1 million new cases diagnosed each year.  Primary liver cancer is rarely discovered early, and often does not respond to current treatment.

About MCT-465 and MCT-485

MCT-465 and MCT-485 are the first of a family of prospective cancer therapeutics based on the use of our patented TLR3 signaling technology.  MC
'/>"/>

SOURCE MultiCell Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. CanCHEW Bio-Technologies, a Medical Marijuana Inc. Product, Dr. George Anastassov Appeared on Small Cap Voice Internet Radio Program To Discuss The CanCHEW Advantage
2. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
3. Life Technologies Announces Second Quarter 2012 Results
4. Radiation Control Technologies, Inc. Announces Exclusive License to Two Patents from the National Institutes of Health
5. Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test
6. Life Technologies and SATuRN Collaborate to Increase Access to HIV Testing in Africa
7. Life Technologies Develops Simplified SAME-DAY STEC Solution for Detecting Multiple Strains of E. coli in Ground Beef
8. Ellman International Launches Multi-stage Growth Plan With Acquisition Of Sandstone Medical Technologies
9. Lifeline Biotechnologies First Warning Systems
10. Life Technologies Signs Collaborative Agreement with Structural Genomics Consortium to Develop First Antibody Master Set for Epigenetic Studies
11. Acquisition of Navigenics Expands Life Technologies Capabilities in Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 Israel ... Israel 2013 , Israel,s 1 st ... October 14 th -15 th in Tel ... most innovative city in the world by the Wall ... BrainTech Israel 2013 will showcase the latest breakthroughs ...
(Date:5/23/2013)... -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ) (Intercept), ... and commercialization of novel bile acid therapeutics to treat ... announced that Mark Pruzanski , MD, ... Deutsche Bank Securities 38th Annual Health Care Conference in ... 2013 at 4:10 p.m. ET. About Intercept ...
(Date:5/23/2013)... 23, 2013  MedVantx, Inc., the company that has ... announced today the Company has completed a major expansion ... pharmaceutical products and the upgrade of its systems to ... in its specialty home delivery pharmacy in ... pharmaceutical manufacturers, physicians, health systems and payors novel distribution ...
Breaking Medicine Technology:Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) -- ... especially among Hispanic teens, according to a new government report. ... to 19 dropped by nearly one half from 1991 to ... to 31 births for every 1,000. From 2007 to ... percent, from 41.5 to about 31. During that time, ...
(Date:5/23/2013)... May 23 (HealthDay News) -- Although a study ... the thinking and memory problems associated with Alzheimer,s ... have been unable to duplicate those findings. ... implications for patient safety since the drug involved ... effects, such as major blood-lipid abnormalities, pancreatitis, headaches, ...
(Date:5/23/2013)... news release is available in French . ... researchers have discovered a novel molecular mechanism that can ... diseases of abnormal growth. In the May 23 edition ... the University of Montreal explain how they found that ... prevents cells from dividing. , "Cells normally monitor the ...
(Date:5/23/2013)... Six innovative research projects have been awarded ... Alliance, the nation's largest private nonprofit funder of Lyme disease ... the epidemiology of, and treatment and cure for Lyme ... to support the innovative research being conducted by some ... in the field today,” said Harriet Kotsoris, MD, LRA’s ...
(Date:5/23/2013)... May 23, 2013 Applied PilotFish ... today that it has added support for the Direct ... the eiConsole for Healthcare. In addition to the product’s ... LLP, FTP, and Web Services, it now offers support ... Protocol is a specification of the Direct Project ...
Breaking Medicine News(10 mins):Health News:U.S. Teen Birth Rate Plummets: Report 2Health News:U.S. Teen Birth Rate Plummets: Report 3Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2Health News:Scientists discover how rapamycin slows cell growth 2Health News:Six Investigators Awarded Lyme Research Alliance Grants 2Health News:Six Investigators Awarded Lyme Research Alliance Grants 3Health News:Six Investigators Awarded Lyme Research Alliance Grants 4Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2
... in the June issue of the Journal of ... the university recruitment strategy and process could raise the ... suggests that specific procedural steps could assist in identifying ... surgery departments. , Despite equaling or exceeding ...
... 2008) The American College of Emergency Physicians (ACEP) ... of Emergency Medicine," an honor the organization bestows upon ... medicine, their communities and their patients. , Dr. ... at Harbor-UCLA Medical Center (LA BioMed) researcher to be ...
... 80 years have passed since the German scientist Hans ... for the field of embryonic development. After dividing a ... specifically, the half that gives rise to the ... other ,back, (dorsal) half that develops into its head, ...
... still to really pan out, expert warns , , THURSDAY, June ... developed an immune response to an investigational vaccine lived twice ... new research shows. , "If you were an immune responder, ... author Dr. Susan Domchek, an associate professor of medicine at ...
... Superior Efficacy to Avastin at Improving Visual Acuity When, ... Percent Patient Share, ... from Decision Resources, WALTHAM, Mass., June 26 ... firms focusing on pharmaceutical and,healthcare issues, finds that Genentech/Novartis,s ...
... June 26 ACM today announced the ... as the company,s new,Executive Vice President of ... operations, and client service management, Ms.,Bryngelson will ... of,ACM,s infrastructure -- including technology, call center ...
Cached Medicine News:Health News:Improving university recruitment process may increase female surgical faculty, study finds 2Health News:LA BioMed researcher named 'Hero of Emergency Medicine' 2Health News:Weizmann Institute scientists discover how an injured embryo can regenerate itself 2Health News:Breast Cancer Vaccines Look Promising 2Health News:Breast Cancer Vaccines Look Promising 3Health News:Because of Its Ability to Generate Higher Total Sales in the United States and Europe, Lucentis Will Earn Clinical Gold Standard Status by 2011 for the Treatment of Diabetic Retinopathy 2Health News:ACM Adds Top Industry Executive to Its Leadership Team 2
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
... best value in high performance electronic pipetting!, ... design reduce hand fatigue and strain , ... ejector , Color coding for easy volume ... greater performance use Hamilton AdvanTip Low Retention ...
Medicine Products: